Literature DB >> 26366401

Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis.

Astrid O Leech1, Rodrigo G B Cruz1, Arnold D K Hill1, Ann M Hopkins1.   

Abstract

Tight junctions (TJ) are multi-protein complexes located at the apicalmost tip of the lateral membrane in polarised epithelial and endothelial cells. Their principal function is in mediating intercellular adhesion and polarity. Accordingly, it has long been a paradigm that loss of TJ proteins and consequent deficits in cell-cell adhesion are required for tumour cell dissemination in the early stages of the invasive/metastatic cascade. However it is becoming increasingly apparent that TJ proteins play important roles in not just adhesion but also intracellular signalling events, activation of which can contribute to, or even drive, tumour progression and metastasis. In this review, we shall therefore highlight cases wherein the gain of TJ proteins has been associated with signals promoting tumour progression. We will also discuss the potential of overexpressed TJ proteins to act as therapeutic targets in cancer treatment. The overall purpose of this review is not to disprove the fact that loss of TJ-based adhesion contributes to the progression of several cancers, but rather to introduce the growing body of evidence that gain of TJ proteins may have adhesion-independent consequences for promoting progression in other cancers.

Entities:  

Keywords:  Cancer; HER2; adhesion; claudin; coxsackievirus and adenovirus receptor (CAR); junctional adhesion molecule A (JAM-A); metastasis; over-expression; tight junction (TJ); tumorigenesis; zonula occludens (ZO) proteins

Year:  2015        PMID: 26366401      PMCID: PMC4543333          DOI: 10.3978/j.issn.2305-5839.2015.08.01

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  149 in total

Review 1.  Loss of tight junction barrier function and its role in cancer metastasis.

Authors:  Tracey A Martin; Wen G Jiang
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 2.  Challenges in monoclonal antibody-based therapies.

Authors:  Haritha Samaranayake; Thomas Wirth; Diana Schenkwein; Jani K Räty; Seppo Ylä-Herttuala
Journal:  Ann Med       Date:  2009       Impact factor: 4.709

3.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Authors:  Scott L Kominsky; Pedram Argani; Dorian Korz; Ella Evron; Venu Raman; Elizabeth Garrett; Alan Rein; Guido Sauter; Olli-P Kallioniemi; Saraswati Sukumar
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

4.  Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer.

Authors:  F Krämer; K White; M Kubbies; K Swisshelm; B H Weber
Journal:  Hum Genet       Date:  2000-09       Impact factor: 4.132

5.  A novel function of junctional adhesion molecule-C in mediating melanoma cell metastasis.

Authors:  Harald F Langer; Valeria V Orlova; Changping Xie; Sunil Kaul; Darius Schneider; Anke S Lonsdorf; Manuela Fahrleitner; Eun Young Choi; Vanessa Dutoit; Manuela Pellegrini; Sylvia Grossklaus; Peter P Nawroth; Gustavo Baretton; Sentot Santoso; Sam T Hwang; Bernd Arnold; Triantafyllos Chavakis
Journal:  Cancer Res       Date:  2011-05-18       Impact factor: 12.701

6.  Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.

Authors:  H Fechner; X Wang; H Wang; A Jansen; M Pauschinger; H Scherübl; J M Bergelson; H P Schultheiss; W Poller
Journal:  Gene Ther       Date:  2000-11       Impact factor: 5.250

7.  Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.

Authors:  Markus D Sachs; Katherine A Rauen; Meera Ramamurthy; Jennifer L Dodson; Angelo M De Marzo; Mathew J Putzi; Mark P Schoenberg; Ronald Rodriguez
Journal:  Urology       Date:  2002-09       Impact factor: 2.649

8.  Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer.

Authors:  Qun Huo; Tetsushi Kinugasa; Lin Wang; Jian Huang; Jun Zhao; Hirotomo Shibaguchi; Motomu Kuroki; Toshihiro Tanaka; Yuichi Yamashita; Kazuki Nabeshima; Hiroshi Iwasaki; Masahide Kuroki
Journal:  Anticancer Res       Date:  2009-03       Impact factor: 2.480

9.  Claudin-4 expression in gastric cancer cells enhances the invasion and is associated with the increased level of matrix metalloproteinase-2 and -9 expression.

Authors:  Tsann-Long Hwang; Tzu-Tsung Changchien; Chee-Chan Wang; Chi-Ming Wu
Journal:  Oncol Lett       Date:  2014-06-27       Impact factor: 2.967

10.  Junctional adhesion molecule-A regulates vascular endothelial growth factor receptor-2 signaling-dependent mouse corneal wound healing.

Authors:  Sharmila Chatterjee; Yan Wang; Melinda K Duncan; Ulhas P Naik
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

View more
  32 in total

Review 1.  Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers.

Authors:  Yosuke Hashimoto; Kiyohito Yagi; Masuo Kondoh
Journal:  Pflugers Arch       Date:  2016-09-15       Impact factor: 3.657

2.  Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models.

Authors:  Roma Yumul; Maximilian Richter; Zhuo-Zhuang Lu; Kamola Saydaminova; Hongjie Wang; Chung-Huei Katherine Wang; Darrick Carter; André Lieber
Journal:  Hum Gene Ther       Date:  2016-04       Impact factor: 5.695

3.  Downregulation of lipolysis-stimulated lipoprotein receptor promotes cell invasion via claudin-1-mediated matrix metalloproteinases in human endometrial cancer.

Authors:  Hiroshi Shimada; Seiro Satohisa; Takayuki Kohno; Takumi Konno; Ken-Ichi Takano; Syunta Takahashi; Tsubasa Hatakeyama; Chihiro Arimoto; Tsuyoshi Saito; Takashi Kojima
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

Review 4.  Claudins as biomarkers of differential diagnosis and prognosis of tumors.

Authors:  Olga P Popova; Alla V Kuznetsova; Svetlana Yu Bogomazova; Alexey A Ivanov
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-09       Impact factor: 4.553

5.  Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression.

Authors:  Antonio G Solimando; Matteo C Da Vià; Patrizia Leone; Paola Borrelli; Giorgio A Croci; Paula Tabares; Andreas Brandl; Giuseppe Di Lernia; Francesco P Bianchi; Silvio Tafuri; Torsten Steinbrunn; Alessandra Balduini; Assunta Melaccio; Simona De Summa; Antonella Argentiero; Hilka Rauert-Wunderlich; Maria A Frassanito; Paolo Ditonno; Erik Henke; Wolfram Klapper; Roberto Ria; Carolina Terragna; Leo Rasche; Andreas Rosenwald; Martin K Kortüm; Michele Cavo; Domenico Ribatti; Vito Racanelli; Hermann Einsele; Angelo Vacca; Andreas Beilhack
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

Review 6.  Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell-Cell Interactions in Tumor Progression.

Authors:  Adam Lauko; Zhaomei Mu; Ulhas P Naik; Justin D Lathia; David H Gutmann
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 12.701

Review 7.  Tight junction proteins in gastrointestinal and liver disease.

Authors:  Mirjam B Zeisel; Punita Dhawan; Thomas F Baumert
Journal:  Gut       Date:  2018-10-08       Impact factor: 31.793

Review 8.  Claudin 1 in Breast Cancer: New Insights.

Authors:  Bowen Zhou; Amanda Moodie; Anne A A Blanchard; Etienne Leygue; Yvonne Myal
Journal:  J Clin Med       Date:  2015-11-27       Impact factor: 4.241

Review 9.  Tight Junctions and the Tumor Microenvironment.

Authors:  Ellaine Salvador; Malgorzata Burek; Carola Y Förster
Journal:  Curr Pathobiol Rep       Date:  2016-07-01

10.  Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.

Authors:  Takuya Kakuki; Makoto Kurose; Ken-Ichi Takano; Atsushi Kondoh; Kazufumi Obata; Kazuaki Nomura; Ryo Miyata; Yakuto Kaneko; Takumi Konno; Syunta Takahashi; Tsubasa Hatakeyama; Takayuki Kohno; Tetsuo Himi; Takashi Kojima
Journal:  Oncotarget       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.